Tenderwize
Wróć do wyszukiwania

Open-house rebate agreement for therapy allergens

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Dec 03, 2027 · 462 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Therapie-Allergene, ATC V01AA05

55/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

55 / 100

Złożoność

48 / 100

Czynniki ryzyka

The notice uses an open-procedure form but states that the arrangement is an open-house model outside procurement law...

To obtain contract start on the next month start, complete and correct documents must be received by the 3rd of the mon...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Non-exclusive rebate agreements for pharmaceutical products concerning therapy allergens, ATC V01AA05.
  • Open-house model with identical, non-individually negotiable contract terms for all eligible pharmaceutical companies.
Pokaż pełne podsumowanie

Open-house supply arrangement for pharmaceutical products (therapy allergens, ATC V01AA05) led by AOK Bayern. The model is explicitly described as non-competitive and open to all interested pharmaceutical companies that meet the stated suitability requirement. No contract value is provided. Submission is possible electronically via DTVP with a qualified electronic signature or in paper form in duplicate originals; German language is required, and non-German documents must be submitted with a German translation.

Ryzyka

The notice uses an open-procedure form but states that the arrangement is an open-house model outside procurement law...

To obtain contract start on the next month start, complete and correct documents must be received by the 3rd of the mon...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • Submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submit the completed and signed contract and the completed and signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Zamawiający

Lokalizacja

München, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE811695320

Działalność

Health

Części (1)

LOT-0001

Open-house rebate agreement for therapy allergens

Open-house non-exclusive rebate agreement for therapy allergens, ATC V01AA05. The lot is described as a supplies contract and the contract conditions are fixed in advance. Place of performance is Germany, region DE212 (Bavaria/Munich area in the notice metadata).

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

DE212, Germany

Czas trwania

Jan 2026 - Jan 2028

Kategoria

Pharmaceutical products

Termin

Deadline Dec 03, 2027

Szczegóły zamówienia

Data publikacji
14 Dec 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
831006-2025

Dokumenty (2)

Dokument zamówienia 1Portal składania ofert 1

Podobne przetargi

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30